Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by LaserStock29on Oct 30, 2019 2:08pm

146 Views

Post# 30287763

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Bottom line.. UHN and TLT 'CHOSE' 7 patients for a reason as their Y1 target April 30th.

Sesen's 2nd cohort is 7 patients

The AUA is in May..

What would be nice is if we treated 7 by Feb 1.. so we have at a minimum 3 at 180 day and 4 at 90 day.. to say we knocked off Sesen.

Theres absolutely zero excuse not to have a Christmas special on BNN to celebrate P1 and P5 & P6 from Phase 1.

This would be absolute scum sucking manipulative garbage

Bullboard Posts

Is China getting serious? Rheinmetall and Almonty Industries profit